Identification of an adult-specific glial progenitor cell

Author(s): Wolswijk G, Noble M

Abstract

We have found that glial progenitor cells isolated from the optic nerves of adult rats are fundamentally different from their counterparts in perinatal animals. In our studies on bipotential oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells, we have seen that O-2Aadult progenitor cells can be distinguished from O-2Aperinatal progenitors by their morphology and antigenic phenotype, their much longer cell cycle time (65 h versus 18 h), slower rate of migration rate (4 microns h-1 versus 21 microns h-1), and their time course of differentiation into oligodendrocytes or type-2 astrocytes in vitro (less than or equal to 3 days versus greater than 5 days). At least some of the differences between O-2Aadult and O-2Aperinatal progenitor cells appear to be clearly related to the differing cellular requirements of the adult and perinatal central nervous system (CNS). The properties of the O-2Aadult progenitor cells may make these cells ideally suited for the needs of the adult CNS, where rapid exponential increases in the number of oligodendrocytes and O-2A progenitor cells would be inappropriate. However, the properties of the O-2Aadult progenitor cells are such that they may not be able to replace oligodendrocytes in sufficient numbers to repair extensive or recurrent damage in the adult brain, such as in patients suffering from the human demyelinating disease multiple sclerosis. Moreover, available information about other tissues suggests that the transition from perinatal to adult progenitor cell types may represent a developmental mechanism of general importance.

Similar Articles

Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination

Author(s): Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, et al.

Axonal swellings and degeneration in mice lacking the major proteolipid of myelin

Author(s): Griffiths I, Klugmann M, Anderson T, Yool D, Thomson C, et al.

Proteolipid protein is required for transport of sirtuin 2 into CNS myelin

Author(s): Werner HB, Kuhlmann K, Shen S, Uecker M, Schardt A, et al.

Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia

Author(s): Edgar JM, McLaughlin M, Yool D, Zhang SC, Fowler JH, et al.

NG2-glia as multipotent neural stem cells: fact or fantasy? Neuron 70: 661-673

Author(s): Richardson WD, Young KM, Tripathi RB, McKenzie I

The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS

Author(s): Reynolds R, Dawson M, Papadopoulos D, Polito A, Di Bello IC, et al.

NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions

Author(s): Chang A, Nishiyama A, Peterson J, Prineas J, Trapp BD

Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis

Author(s): Scolding N, Franklin R, Stevens S, Heldin CH, Compston A, et al.

Origin of oligodendrocytes in the subventricular zone of the adult brain

Author(s): Menn B, Garcia-Verdugo JM, Yaschine C, Gonzalez-Perez O, Rowitch D, et al.

Cdk2 loss accelerates precursor differentiation and remyelination in the adult central nervous system

Author(s): Caillava C, Vandenbosch R, Jablonska B, Deboux C, Spigoni G, et al.

Inhibition of CNS remyelination by the presence of semaphorin 3A

Author(s): Syed YA, Hand E, Möbius W, Zhao C, Hofer M, et al.

Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS

Author(s): Fancy SP, Baranzini SE, Zhao C, Yuk DI, Irvine KA, et al.

Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination

Author(s): Fancy SP, Harrington EP, Yuen TJ, Silbereis JC, Zhao C, et al.

bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS

Author(s): Arnett HA, Fancy SP, Alberta JA, Zhao C, Plant SR, et al.

F3/contactin acts as a functional ligand for Notch during oligodendrocyte maturation

Author(s): Hu QD, Ang BT, Karsak M, Hu WP, Cui XY, et al.

Notch receptor activation inhibits oligodendrocyte differentiation

Author(s): Wang S, Sdrulla AD, diSibio G, Bush G, Nofziger D, et al.

Retinoid X receptor gamma signaling accelerates CNS remyelination

Author(s): Huang JK, Jarjour AA, NaitOumesmar B, Kerninon C, Williams A, et al.

CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination

Author(s): Patel JR, McCandless EE, Dorsey D, Klein RS

Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2

Author(s): Sloane JA, Batt C, Ma Y, Harris ZM, Trapp B, et al.

The immunomodulator FTY720 has a direct cytoprotective effect in oligodendrocyte progenitors

Author(s): Coelho RP, Payne SG, Bittman R, Spiegel S, Sato-Bigbee C

Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices

Author(s): Miron VE, Ludwin SK, Darlington PJ, Jarjour AA, Soliven B, et al.

BG-12 (dimethyl fumarate): a review of mechanism of action, efficacy, and safety

Author(s): Fox RJ, Kita M, Cohan SL, Henson LJ, Zambrano J, et al.

Quetiapinefumarate for the treatment of multiple sclerosis: focus on myelin repair

Author(s): Zhornitsky S, Wee Yong V, Koch MW, Mackie A, Potvin S, et al.

Rejuvenation of aged progenitor cells by exposure to a young systemic environment

Author(s): Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, et al.

Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis? Brain 130: 2554-2565

Author(s): Williams A, Piaton G, Aigrot MS, Belhadi A, Théaudin M, et al.

Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis

Author(s): Chang A, Tourtellotte WW, Rudick R, Trapp BD

Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation

Author(s): John GR, Shankar SL, Shafit-Zagardo B, Massimi A, Lee SC, et al.

Notch1 signaling plays a role in regulating precursor differentiation during CNS remyelination

Author(s): Zhang Y, Argaw AT, Gurfein BT, Zameer A, Snyder BJ, et al.

Negative regulation of central nervous system myelination by polysialylated-neural cell adhesion molecule

Author(s): Charles P, Hernandez MP, Stankoff B, Aigrot MS, Colin C, et al.